“Mechanistic Insights and Therapeutic Approaches to Restore Muscle Function in Dystroglycanopathy Muscular Dystrophy.” Nationwide Children’s Hospital/Ohio State University Myology Course, Columbus, Ohio, August 27, 2024.

“Mechanistic Insights and Therapeutic Approaches to Restore Muscle Function in Muscular Dystrophy.” 65th Annual Meeting of Japanese Society of Neurology, Tokyo, Japan, May 30, 2024. 

Wash U Compass Fireside Chat, St. Louis, Missouri, Virtual, May 15, 2024.

“Mechanistic Insights and Therapeutic Approaches to Restore Muscle Function in Muscular Dystrophy.” American Society of Gene & Cell Therapy Annual Meeting, Baltimore, Maryland, May 8, 2024.

“Beyond Gene Replacement for Muscular Dystrophy: The Need to Restore Normal Muscle Function.” Association of University Cardiologists Meeting, Charleston, South Carolina, February 22, 2024.

“Beyond Gene Replacement for Muscular Dystrophy: The Need to Restore Normal Muscle Function.” University of Iowa Neurology Grand Rounds, Iowa City, Iowa, December 12, 2023.

“Mechanistic Insights and Therapeutic Approaches for Matriglycan-Deficient Muscular Dystrophy.” Society of Glycobiology Annual Meeting, Big Island, Hawaii, November 6, 2023.

“Beyond Gene Replacement for Muscular Dystrophy: the Need to Restore Normal Muscle Function.” Presidents Lecture Series at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, September 26, 2023. 

Wash U Compass Fireside Chat, St. Louis, Missouri, Virtual, July 19, 2023. 

“Regulating Dystroglycan Function via LARGE1 Elongation of Matriglycan.” 7th International Workshop for Glycosylation Defects in Muscular Dystrophy, Charlotte, North Carolina, May 25, 2023.

“Mechanistic Insights and Therapeutic Approaches for Matriglycan-Deficient Muscular Dystrophy.” Baylor College of Medicine Child Neurology Grand Rounds, Houston, Texas, April 5, 2023.

“Matriglycan: function and mechanism of elongation via LARGE1.” Glycobiology Gordon Research Conference, Ventura, California, March 16, 2023.

“Mechanistic Insights and Therapeutic Approaches for Matriglycan-Deficient Muscular Dystrophy.” University of Rochester Inaugural Paul LaCelle Lecture, Rochester, New York, November 2, 2022.

“Mechanistic Insights and Therapeutic Approaches for Matriglycan-Deficient Muscular Dystrophy.” University of Iowa Neuromuscular-Neurogenetics Symposium, Iowa City, Iowa, September 30, 2022.

“Mechanistic Insights and Therapeutic Approaches for Matriglycan-Deficient Muscular Dystrophy.” International Conference on Muscle Wasting, Ascona, Switzerland, September 15, 2022. 

“LARGE1 Mediates Elongation of Matriglycan: Insights into the Pathogenesis of Muscular Dystrophy.” Scripps Molecular Medicine Seminar, San Diego, California, September 1, 2022.

“Regulation of matriglycan synthesis.” The 3rd ENMC Workshop on Dystroglycan and the Dystroglycanopathies, Hoofddorp, The Netherlands, June 10, 2022.

“Structural Basis of LARGE1-Mediated Elongation of Matriglycan on Dystroglycan.” Tamio Yamakawa Award Lecture, Osaka, Japan, Virtual, December 6, 2021.

“POMK Regulates Dystroglycan Function via LARGE1-Mediated Elongation of Matriglycan: Insights into the Pathogenesis of Muscular Dystrophy.” Joint Glycobiology Meeting, Heidelberg, Germany, Virtual, October 7, 2021.

“Structural Basis of Dystroglycan Function and the Pathogenesis of Muscular Dystrophy.” ASBMB Herbert Tabor Award Lecture, San Diego, California, Virtual (Voted one of the "Most Favorited" sessions and presentations, Experimental Biology 2021 conference), April 21, 2021.

“Regulation of dystroglycan function via LARGE1-mediated elongation of matriglycan. ” San Diego Glycobiology Symposium, San Diego, California, Virtual, April 1, 2021.

“Structural Basis of Dystroglycan Function and the Pathogenesis of Muscular Dystrophy.” Albert Einstein College of Medicine, Cell Biology Outside Speaker Seminar Series, Bronx, New York, Virtual, March 24, 2021.

“Structural Basis of Dystroglycan Function and the Pathogenesis of Muscular Dystrophy.” Regeneron Seminar Series, Tarrytown, New York, Virtual, January 25, 2021.

“Dystroglycan Function and the Pathogenesis of Muscular Dystrophy.” 12th International GlycoT Conference, San Diego, California, Virtual, March 18, 2020.

“POMK and Dystroglycan Function.” University of Iowa Neuromuscular-Neurogenetics Symposium, Iowa City, Iowa, Virtual, October 2, 2020.

“Dystroglycanopathies.” Congenital Disorders of Glycosylation Pre-Meeting Course, Guadalajara Jalisco, Mexico, Virtual, October 3, 2020.